David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is President Emeritus and Distinguished Professor of Biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He also served as the director of the Joint Center for Translational Medicine, which joined Caltech and UCLA in a program to translate basic scientific discoveries into clinical realities. He also formerly served as president of Rockefeller University from 1990 to 1991, founder and director of the Whitehead Institute of Biomedical Research from 1982 to 1990, and was president of the American Association for the Advancement of Science in 2007.
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
E. Premkumar Reddy is a molecular biologist specialising in molecular oncology. He is the Director of Experimental Cancer Therapeutics program and Professor in the Departments of Oncological Sciences and Structural and Chemical Biology at the Mount Sinai School of Medicine.
Edison T. Liu, M.D. is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). As CEO of The Jackson Laboratory, the organization doubled revenue, faculty and personnel, expanded globally from two campuses to six, established 13 endowed chairs, and increased the institutional endowment by five-fold. He is currently a Professor and Honorary Fellow at the institution. Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.
John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.
The UNC Lineberger Comprehensive Cancer Center is a cancer research and treatment center at the University of North Carolina at Chapel Hill. One of 52 National Cancer Institute-designated comprehensive cancer centers in the United States, its clinical base is the N.C. Cancer Hospital, part of the UNC Health Care system. UNC Lineberger is the only public NCI-designated comprehensive cancer center in the state of North Carolina. The current director is H. Shelton Earp III who succeeded current NCI director Norman Sharpless.
Frank W. Putnam was an American biochemist and university professor.
Ralph R. Isberg is a professor at Tufts University School of Medicine known for his contributions to understanding microbial pathogenesis. He is a member of the American National Academy of Sciences and was an investigator of the Howard Hughes Medical Institute for 27 years. A microbiologist, Isberg has published over 185 peer-reviewed articles and is or has been an editor of the Proceedings of the National Academy of Sciences, PLoS Pathogens, and Journal of Experimental Medicine, among others.
Arnold B. Rabson is an American scientist and biomedical researcher. He is the director of the Child Health Institute of New Jersey and the Laura Gallagher Chair of Developmental Biology at Robert Wood Johnson Medical School. Rabson is a Fellow of the American Association for the Advancement of Science.
Richard D. Klausner is an American scientist who served as the 11th director of the National Cancer Institute of the United States.
Gerald T. Keusch is an American physician-scientist and academic administrator. Keusch is the associate provost for global health at Boston University Medical Campus and a professor of international health and medicine at Boston University School of Public Health. He was the director of John E. Fogarty International Center and the associate director of international research at the National Institutes of Health from 1998 to 2003.
Mary F. Kearney is an American biologist. She is a senior scientist and head of the translational research section in the HIV dynamics and replication program at the National Cancer Institute.
Munira Adnan Basrai is an American geneticist researching genome stability and cell cycle regulation in yeast and human cancers. She is a senior investigator at the National Cancer Institute.
Sheue-yann Cheng is an American molecular geneticist who pioneered the development of mouse models to understand the molecular basis of diseases due to mutations of thyroid hormone receptors. Cheng is a senior investigator at the National Cancer Institute and chief of the gene regulation section.
Barbara K. Felber is an American biologist specialized in human retrovirus pathogensis and gene regulation. She is a senior investigator in the vaccine branch at the National Cancer Institute.
Wei-Shau Hu is an American geneticist specialized in HIV research, retroviral recombination, RNA packaging, and virus assembly. She is a senior investigator at the National Cancer Institute and head of the viral recombination section. She was an associate professor at West Virginia University.
Rajvir Dahiya, is an American Indian medical oncology scientist with expertise in urology oncology diagnosis, prognosis and risk assessment through genetic and epigenetic technology. Dahiya retired in 2021 as a Professor Emeritus and Director of Urology Oncology Research Center at the Veterans Affairs Medical Center and the University of California San Francisco School of Medicine (UCSF) after 34 years of service.
Hannah P. Yang is an American cancer epidemiologist who is a staff scientist and associate director of scientific operations in the National Cancer Institute's division of cancer epidemiology and genetics.
